6 Safe Yields Whether Q2 Is Foggy or Fair

Investment Underground anticipates two scenarios for Q2 2011. Investors will head for the exits amid choppy markets, congressional debt grappling and QE2 curtailment, or investors will scoop up bargains paying dividends, often paying yields in excess of company bonds. Either way, these names should stand out from market peers: Johnson & Jonson (JNJ): The healthcare giant is making moves to buy device maker, Synthes, and looks like a leader in earnings season. The company holds a price/sales ratio of 2.7, not much higher than its 10-year low of 2.14, and sports a P/E ratio of 12.6. While recent product recalls could hurt the JNJ brand and cost millions of dollars, the firm is too diverse, too financially healthy, and too well run to not overcome the setback. And considering that the firm holds the #1 or #2 spot in 70% of its products, a product recall would have to cause... Read more